- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
Patent holdings for IPC class A61K 39/42
Total number of patents in this class: 1804
10-year publication summary
76
|
119
|
88
|
94
|
94
|
122
|
165
|
190
|
145
|
39
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Rockefeller University | 562 |
39 |
Vanderbilt University | 1731 |
35 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
34 |
Duke University | 2872 |
32 |
Humabs Biomed SA | 115 |
28 |
Crucell Holland B.V. | 121 |
22 |
Albert Einstein College of Medicine, Inc. | 528 |
21 |
Regeneron Pharmaceuticals, Inc. | 3650 |
20 |
The Scripps Research Institute | 1364 |
20 |
The Trustees of the University of Pennsylvania | 4122 |
19 |
California Institute of Technology | 3884 |
18 |
The Regents of the University of California | 18943 |
15 |
Institute for Research in Biomedicine | 95 |
15 |
International AIDS Vaccine Initiative | 86 |
15 |
Temasek Life Sciences Laboratory Limited | 139 |
15 |
Xiamen University | 488 |
14 |
Visterra, Inc. | 110 |
13 |
Beth Israel Deaconess Medical Center, Inc. | 844 |
12 |
MedImmune, LLC | 467 |
12 |
The University of Chicago | 1282 |
12 |
Other owners | 1393 |